In 2017, the World Health Organization (WHO) introduced the third Global Patient Safety Challenge, Medication Without Harm. Interviews, focus groups, and document analysis were conducted at four UK hospitals to evaluate how they were addressing the domains and priority areas laid out in the WHO’s Patient Safety Challenge. Although all areas were addressed, additional focus is needed on patient and public involvement, transitions of care, and polypharmacy.